Investors saw the bond sale as a sign the transaction is on track with antitrust regulators, but the deal’s closure is still not guaranteed, according to The Wall Street Journal.
The Aetna-Humana deal is under intense scrutiny from antitrust regulators, as the transaction comes alongside the proposed merger of Indianapolis-based Anthem and Hartford, Conn.-based Cigna. If the two transactions go through, the health insurance landscape drastically changes to one with three key payers instead of five.
Aetna reiterated Thursday that it expects to complete the deal with Humana later this year.
More articles on payer issues:
BCBS of North Carolina raises rates after $282M loss on ACA customers
Empire, BCBS to split after unsuccessful negotiations
UnitedHealth to exit Illinois’ ACA exchange
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
